Graig Suvannavejh
Stock Analyst at Mizuho Securities
(4.80)
# 532
Out of 5,074 analysts
865
Total ratings
45.4%
Success rate
17.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Graig Suvannavejh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYPT EyePoint | Downgraded: Hold | $39 → $0.5 | $0.4281 | +16.80% | 47 | Oct 20, 2026 | |
| VSTM Verastem | Reiterated: Buy | $13 → $14 | $10.06 | +39.17% | 37 | Oct 16, 2026 | |
| HRMY Harmony Biosciences Holdings | Reiterated: Buy | $51 | $36.03 | +41.55% | 84 | Oct 12, 2026 | |
| ALEC Alector | Reiterated: Hold | $1.5 | $1.83 | -18.03% | 40 | Oct 6, 2026 | |
| INSM Insmed | Reiterated: Buy | $195 | $95.06 | +105.13% | 59 | Oct 5, 2026 | |
| RGNX REGENXBIO | Initiated Coverage: Buy | $22 | $7.17 | +206.83% | 1 | Oct 5, 2026 | |
| IMRX Immuneering | Reiterated: Buy | $12 | $3.81 | +214.96% | 41 | Oct 2, 2026 | |
| IMMX Immix Biopharma | Reiterated: Buy | $26 | $8.35 | +211.38% | 10 | Sep 30, 2026 | |
| LONA LeonaBio | Reiterated: Buy | $15 | $4.97 | +201.81% | 46 | Sep 23, 2026 | |
| ALKS Alkermes | Reiterated: Buy | $24 → $65 | $44.18 | +47.13% | 4 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $4.13 | +699.03% | 27 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $316 | $156.07 | +102.47% | 159 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 | $126.39 | +89.89% | 10 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 → $234 | $150.27 | +55.72% | 13 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $36.12 | +38.43% | 29 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.54 | +231.56% | 25 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $42 | $28.57 | +47.01% | 46 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.4057 | +885.95% | 26 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $10.65 | +181.69% | 23 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $72.08 | +38.73% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.41 | +231.95% | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $32.12 | +8.97% | 32 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $5 | $14.04 | -64.39% | 7 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1,500 → $75 | $0.1855 | n/a | 3 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.025 | n/a | 12 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 26.50 → CHF 17.00 | CHF 4.24 | n/a | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €16.50 | €21.25 | n/a | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $50 | $124.54 | n/a | 4 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $6.5 | $1.58 | n/a | 2 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €14.00 → €6.00 | €1.76 | n/a | 2 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €57.00 → €44.00 | €27.62 | n/a | 3 | Oct 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €14.00 → €14.50 | €2.40 | n/a | 2 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $18 → $16 | $90.90 | n/a | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $26 | $62.33 | n/a | 2 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €4.00 → €3.50 | €1.30 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $135 → $96 | $85.78 | n/a | 5 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $28 | $10.49 | n/a | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $31 | $39.99 | n/a | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $75.03 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $55 | $32.20 | n/a | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $7 | $9.68 | n/a | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $98 → $90 | $31.40 | n/a | 2 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $4.75 | $1.50 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $128 → $145 | $214.65 | n/a | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $37 | $3.60 | n/a | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $19 | $3.64 | n/a | 3 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $60 | $320.13 | n/a | 1 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $154 | $875.76 | n/a | 1 | Dec 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $53.16 | n/a | 2 | Sep 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $11 | $3.20 | n/a | 5 | Jul 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1 | $0.000101 | n/a | 4 | May 28, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $2.15 | n/a | 1 | Apr 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $96 | $307.82 | n/a | 2 | Feb 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $4.12 | n/a | 2 | Feb 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $2 | $1.99 | n/a | 3 | Oct 15, 2013 |
EyePoint
Oct 20, 2026
Downgraded: Hold
Price Target: $39 → $0.5
Current: $0.4281
Upside: +16.80%
Verastem
Oct 16, 2026
Reiterated: Buy
Price Target: $13 → $14
Current: $10.06
Upside: +39.17%
Harmony Biosciences Holdings
Oct 12, 2026
Reiterated: Buy
Price Target: $51
Current: $36.03
Upside: +41.55%
Alector
Oct 6, 2026
Reiterated: Hold
Price Target: $1.5
Current: $1.83
Upside: -18.03%
Insmed
Oct 5, 2026
Reiterated: Buy
Price Target: $195
Current: $95.06
Upside: +105.13%
REGENXBIO
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $7.17
Upside: +206.83%
Immuneering
Oct 2, 2026
Reiterated: Buy
Price Target: $12
Current: $3.81
Upside: +214.96%
Immix Biopharma
Sep 30, 2026
Reiterated: Buy
Price Target: $26
Current: $8.35
Upside: +211.38%
LeonaBio
Sep 23, 2026
Reiterated: Buy
Price Target: $15
Current: $4.97
Upside: +201.81%
Alkermes
Sep 22, 2026
Reiterated: Buy
Price Target: $24 → $65
Current: $44.18
Upside: +47.13%
Sep 14, 2026
Reiterated: Buy
Price Target: $33
Current: $4.13
Upside: +699.03%
Sep 11, 2026
Reiterated: Buy
Price Target: $316
Current: $156.07
Upside: +102.47%
Sep 10, 2026
Reiterated: Buy
Price Target: $240
Current: $126.39
Upside: +89.89%
Sep 9, 2026
Reiterated: Buy
Price Target: $220 → $234
Current: $150.27
Upside: +55.72%
Sep 1, 2026
Reiterated: Buy
Price Target: $50
Current: $36.12
Upside: +38.43%
Aug 20, 2026
Reiterated: Buy
Price Target: $25
Current: $7.54
Upside: +231.56%
Aug 19, 2026
Reiterated: Buy
Price Target: $24 → $42
Current: $28.57
Upside: +47.01%
Aug 17, 2026
Reiterated: Buy
Price Target: $4
Current: $0.4057
Upside: +885.95%
Aug 11, 2026
Reiterated: Buy
Price Target: $30
Current: $10.65
Upside: +181.69%
Aug 11, 2026
Reiterated: Buy
Price Target: $100
Current: $72.08
Upside: +38.73%
Aug 11, 2026
Reiterated: Buy
Price Target: $8
Current: $2.41
Upside: +231.95%
Aug 7, 2026
Reiterated: Hold
Price Target: $35
Current: $32.12
Upside: +8.97%
Dec 9, 2025
Reiterated: Buy
Price Target: $4 → $5
Current: $14.04
Upside: -64.39%
Oct 2, 2025
Downgraded: Hold
Price Target: $1,500 → $75
Current: $0.1855
Upside: n/a
Aug 26, 2025
Rated: Hold
Price Target: n/a
Current: $0.025
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: CHF 26.50 → CHF 17.00
Current: CHF 4.24
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: €16.50
Current: €21.25
Upside: n/a
Nov 15, 2021
Reiterated: Buy
Price Target: $55 → $50
Current: $124.54
Upside: n/a
Nov 9, 2021
Reiterated: Hold
Price Target: $13 → $6.5
Current: $1.58
Upside: n/a
Oct 28, 2021
Reiterated: Buy
Price Target: €14.00 → €6.00
Current: €1.76
Upside: n/a
Oct 5, 2021
Reiterated: Sell
Price Target: €57.00 → €44.00
Current: €27.62
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: €14.00 → €14.50
Current: €2.40
Upside: n/a
Aug 4, 2021
Reiterated: Sell
Price Target: $18 → $16
Current: $90.90
Upside: n/a
Jul 20, 2021
Reiterated: Hold
Price Target: $16 → $26
Current: $62.33
Upside: n/a
Jun 29, 2021
Reiterated: Hold
Price Target: €4.00 → €3.50
Current: €1.30
Upside: n/a
May 14, 2021
Reiterated: Hold
Price Target: $135 → $96
Current: $85.78
Upside: n/a
Apr 20, 2021
Initiated Coverage: Hold
Price Target: $28
Current: $10.49
Upside: n/a
Apr 19, 2021
Initiated Coverage: Hold
Price Target: $31
Current: $39.99
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $75.03
Upside: n/a
Feb 3, 2021
Reiterated: Buy
Price Target: $36 → $55
Current: $32.20
Upside: n/a
Jan 15, 2021
Reiterated: Buy
Price Target: $28 → $7
Current: $9.68
Upside: n/a
Dec 21, 2020
Reiterated: Sell
Price Target: $98 → $90
Current: $31.40
Upside: n/a
Nov 23, 2020
Initiated Coverage: Hold
Price Target: $4.75
Current: $1.50
Upside: n/a
Nov 11, 2020
Reiterated: Sell
Price Target: $128 → $145
Current: $214.65
Upside: n/a
Oct 20, 2020
Initiated Coverage: Hold
Price Target: $37
Current: $3.60
Upside: n/a
May 11, 2020
Reiterated: Buy
Price Target: $14 → $19
Current: $3.64
Upside: n/a
Sep 24, 2019
Initiated Coverage: Hold
Price Target: $60
Current: $320.13
Upside: n/a
Dec 17, 2018
Initiated Coverage: Buy
Price Target: $154
Current: $875.76
Upside: n/a
Sep 23, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $53.16
Upside: n/a
Jul 1, 2014
Downgraded: Hold
Price Target: $10 → $11
Current: $3.20
Upside: n/a
May 28, 2014
Downgraded: Hold
Price Target: $2 → $1
Current: $0.000101
Upside: n/a
Apr 1, 2014
Downgraded: Hold
Price Target: $3
Current: $2.15
Upside: n/a
Feb 13, 2014
Reiterated: Buy
Price Target: $62 → $96
Current: $307.82
Upside: n/a
Feb 3, 2014
Reiterated: Buy
Price Target: $27
Current: $4.12
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $15 → $2
Current: $1.99
Upside: n/a